abstract |
The present invention relates to novel double-stranded RNA oligonucleotides that reduce tyrosinase expression, their use for cosmetic and / or pharmaceutical purposes, and to their combination with cationic particles having a zeta potential of 10 to 80 mV and a size of 1 μm or less. .n n n Tyrosinase, RNA oligonucleotide, zeta potential, cationic particles |